Natlimus 0.25mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Everolimus (0.25mg)
Overview Natlimus 0.25mg Tablet
Immunosuppressant tablets of Natlimus (0.25mg) prevent organ rejection following transplantation by modulating the immune system's response to the new organ. This medication also features in combination therapies for breast, pancreatic, lung, and kidney cancers. Adhere strictly to your physician's prescribed dosage and regimen for Natlimus 0.25mg Tablets. It can be administered with or without food, but maintaining consistent daily timing is crucial. An overdose can result in serious adverse effects. Common side effects include infections (respiratory and otherwise), fever, cough, fatigue, diarrhea, and respiratory tract irritation. Persistent or bothersome side effects warrant immediate medical attention. Report any allergic reactions (skin rashes, breathing difficulties, coughing, swelling) to your doctor immediately. Seek medical advice promptly if you experience excessive thirst, frequent urination, respiratory distress, fever, cough, or require vaccinations while using this medication. Prior to commencing treatment, disclose all existing medications and health conditions to your doctor. Pregnant or breastfeeding individuals should inform their physician before starting Natlimus. Regular blood tests may be recommended to monitor the medication's impact. As Natlimus may influence fertility in both men and women, discuss family planning with your doctor.
Uses of Natlimus 0.25mg Tablet
Preventing transplanted organ rejection
Major Benefits of Natlimus 0.25mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 0.25mg Natlimus tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Natlimus 0.25mg Tablet:
- Infection
- Fever
- Cough
- Fatigue
- Diarrhea
- Upper respiratory tract infection
How to use Natlimus 0.25mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Natlimus 0.25mg Tablet can be consumed with or without food, though consistent timing is recommended for optimal results.
How Natlimus 0.25mg Tablet works:
Natlimus 0.25mg tablets modulate the body's immune response, thereby reducing the risk of organ transplant rejection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Natlimus 0.25mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Natlimus 0.25mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Natlimus 0.25mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Natlimus 0.25mg Tablet, a medication that commonly causes fatigue. This fatigue is a potential side effect of Natlimus 0.25mg Tablet.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment can safely use Natlimus 0.25mg tablets without requiring a dosage modification.
LiverCAUTION
Patients with liver impairment should use Natlimus 0.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Natlimus 0.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Natlimus 0.25mg Tablet :
NA
Facts to Know About Natlimus 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Macrolide Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
3,018 People bought this recently